HCC 18-42
Have you been diagnosed with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer? Has your doctor recommended that you start taking brigatinib (brand name Alunbrig) to treat your disease? If so, you may be eligible to participate in this study to help researchers study how often pulmonary (lung) issues such as breathing issues, pneumonia, etc. occur to patients taking brigatinib.
